导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.29% | 475/1050 |
| 近一周 | -0.20% | 466/1104 |
| 近一月 | -4.08% | 345/1103 |
| 近一季 | -7.95% | 538/1094 |
| 近半年 | -1.88% | 554/1074 |
| 近一年 | 7.36% | 393/1020 |
| 近两年 | 86.66% | 256/926 |
| 近三年 | 37.28% | 348/834 |
| 成立以来 | 92.59% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.56% 443/1070 |
13.82% 475/1101 |
- - |
- - |
| 2025 | 38.66% 340/1065 |
6.60% 310/1014 |
6.84% 200/1038 |
18.13% 659/1050 |
3.05% 240/1065 |
| 2024 | -0.15% 586/1011 |
-9.54% 757/960 |
-7.26% 757/983 |
13.65% 330/991 |
4.72% 150/1011 |
| 2023 | -3.19% 167/952 |
8.77% 152/880 |
-4.55% 497/895 |
-2.81% 194/915 |
-4.06% 413/952 |
| 2022 | -16.59% 210/867 |
-15.16% 271/773 |
8.41% 335/806 |
-11.34% 325/845 |
2.27% 310/867 |
| 2021 | 28.43% 82/740 |
0.89% 113/580 |
15.28% 232/659 |
4.12% 144/704 |
6.05% 179/740 |
| 2020 | 39.07% 301/554 |
-0.64% 178/419 |
19.57% 292/466 |
12.77% 187/517 |
3.82% 455/554 |
| 2019 | 31.32% 282/410 |
30.18% 368/1146 |
-5.74% 756/1228 |
-0.86% 354/390 |
7.94% 240/410 |
| 2018 | -23.37% 123/349 |
- - |
-12.84% 644/990 |
-4.10% 421/1000 |
-6.96% 103/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 创金合信量化多因子股票C VS. 东吴新产业精选股票A(580008) |